Exodus Movement, Inc. May 2025 Treasury Update and Monthly Metrics
By GlobeNewswire Published on June 10, 2025, 16:20 IST
OMAHA, Neb., June 10, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) ('Exodus'), a leading self-custodial cryptocurrency platform, today announced an update to selected digital asset holdings of Exodus' corporate treasury, as well as updated user and exchange provider processed volume metrics, as of May 31, 2025:
Selected Digital Asset Holdings (Unaudited)Bitcoin (BTC): 2,038 BTC as of May 31, 2025Ethereum (ETH): 2,721 ETH as of May 31, 2025
Solana (SOL): 29,109 SOL as of May 31, 2025
Users
Monthly Active Users (MAUs): 2.2 million as of May 31, 2025, of which approximately 675,000 are Passkeys Wallets.
Swap Volume
Exchange provider processed volume was $486M for the month of May 2025, of which $69M (14%) originated from our XO Swap partners.
Exodus CEO, JP Richardson, commented: 'Our monthly active users benefited from a brief May promotion aimed at Passkeys Wallets that we do not expect to reoccur in June. However, this performance demonstrates the power of our Passkeys tech, enabling a scalable, hassle free, and under thirty second wallet onboarding experience ideal for stablecoin adoption. Additionally, we believe our sponsorship of the Las Vegas BTC 2025 conference further reinforced Exodus' market leadership in bringing crypto, including Bitcoin and stablecoins, to the wider public.'
'Our operations continue to generate Bitcoin,' Exodus CFO James Gernetzke remarked. 'In particular, incremental increases in our BTC units held demonstrate the real-world benefits of our operational philosophy. In addition, we plan to continue to drive shareholder value by executing upon our organic growth initiatives, pursuing potential strategic acquisitions, and expanding our digital assets treasury.'
About Exodus
Exodus is a financial technology leader empowering individuals and businesses with secure, user-friendly crypto software solutions. Since 2015, Exodus has made digital assets accessible to everyone through its multi-asset crypto wallets prioritizing design and ease of use.
With self-custodial wallets, Exodus puts customers in full control of their funds, enabling them to swap, buy, and sell crypto. Its business solutions include Passkeys Wallet and XO Swap, industry-leading tools for embedded crypto wallets and swap aggregation.
Exodus is committed to driving the future of accessible and secure finance. Learn more at exodus.com or follow us on X at x.com/exodus.
Investor Contact
[email protected]
Disclosure Information
Exodus uses the following as means of disclosing material nonpublic information and for complying with disclosure obligations under Regulation FD: websites exodus.com/investors and exodus.com/blog; press releases; public videos, calls, and webcasts; and social media: X (@exodus and JP Richardson's feed @jprichardson), Facebook, LinkedIn, and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements are based on our beliefs and assumptions and on information currently available to us as of the date hereof. In some cases, you can identify forward-looking statements by the following words: 'will,' 'expect,' 'would,' 'should,' 'intend,' 'believe,' 'expect,' 'likely,' 'believes,' 'views', 'estimates,' or other comparable terminology.
Forward-looking statements in this document include, but are not limited to, management statements regarding management's confidence in our products, services, business trajectory and plans, expectations regarding demand for our products, and optionality around future securities offerings, including to finance acquisitions. Such forward-looking statements involve a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those expressed or implied by our forward-looking statements. Such factors include those set forth in 'Item 1. Business' and 'Item 1A. Risk Factors' of Form 10-K filed with the Securities and Exchange Commission (the 'SEC') on March 6, 2025, as well as in our other reports filed with the SEC from time to time.
All forward-looking statements are expressly qualified in their entirety by such cautionary statements. Readers are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we undertake no obligation to update or revise any forward-looking statements that have been made to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
12 minutes ago
- Associated Press
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC ™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact: Barbara Ryan [email protected] (203) 274-2825
Business Insider
an hour ago
- Business Insider
SMCI, MSTR, or UBER: Which Is the Most Attractive Large-Cap Stock?
Investors often look for opportunities to invest in large-cap stocks as they are generally associated with companies having a well-established business model and solid growth potential. The large-cap stocks have a market capitalization between $10 billion and $200 billion. Using TipRanks' Stock Comparison Tool, we placed Super Micro Computer (SMCI), Strategy (MSTR), and Uber Technologies (UBER) against each other to find the most attractive large-cap stock, according to Wall Street analysts. Confident Investing Starts Here: Super Micro Computer (NASDAQ:SMCI) Super Micro Computer, or Supermicro, offers AI server and storage solutions. SMCI stock has rallied about 41% so far in 2025, with issues like delayed filing of financial statements and the threat of delisting in the rearview mirror. In fact, investors are looking beyond the company's dismal results for the third quarter of Fiscal 2025, as they believe that SMCI is well-positioned to capture growth opportunities in the AI server market. Specifically, Super Micro Computer's DLC (direct liquid cooling) technology has an edge over rivals' offerings in terms of power and cost savings. Also, deals such as the $20 billion partnership with DataVolt to develop hyperscale AI campuses in Saudi Arabia and the U.S. have bolstered investors' confidence in SMCI stock. What Is the Forecast for SMCI Stock? Last month, Mizuho analyst Vijay Rakesh raised the price target for SMCI stock to $40 from $32 but retained a Hold rating. The 5-star analyst upgraded price targets for many AI server-related stocks to reflect increased demand and momentum across the supply chain. While Rakesh acknowledges Super Micro Computer's leadership in AI server deployments, he maintains a neutral stance owing to intense rivalry and weak AI server margins. Overall, Wall Street has a Moderate Buy consensus rating on Super Micro Computer stock based on six Buys, five Holds, and one Sell recommendation. The average SMCI stock price target of $40.83 indicates about 5% downside risk. Strategy (NASDAQ:MSTR) Strategy, earlier known as MicroStrategy, is the world's largest Bitcoin (BTC-USD) treasury company. It also offers AI-powered enterprise analytics software. MSTR stock is considered to be an attractive crypto play and an alternative to making a direct investment in the largest cryptocurrency, Bitcoin. Interestingly, Strategy accumulates Bitcoin by using proceeds from equity and debt financings, as well as cash flows from its operations. Based on its latest purchase of 1045 Bitcoin units between June 3 and 8, Strategy now holds 582,000 BTC, having a value of $63.8 billion. Is MSTR a Buy, Hold, or Sell? Recently, TD Cowen analyst Lance Vitanza reiterated a Buy rating on Strategy stock with a price target of $590. Commenting on MSTR's offering for its Strife (STRF) preferred stock, the 5-star analyst stated that he expects this offering to create significantly greater accretion for common shareholders compared to the company's common stock and STRK (Strike) at-the-money offerings. Vitanza continues to view MSTR stock as a 'compelling vehicle for bitcoin investors.' However, Monness analyst Gustavo Gala has a Sell rating on MSTR stock due to several reasons, including rising competition from companies like GameStop (GME), which are also following a Bitcoin-focused strategy. Overall, Wall Street has a Strong Buy consensus rating on Strategy stock based on 12 Buys and one Sell recommendation. The average MSTR stock price target of $524.92 implies about 34.2% upside potential. MSTR stock has risen 35% year-to-date. Uber Technologies (NYSE:UBER) Ride-hailing and delivery platform Uber Technologies is impressing investors with its resilient performance despite macro challenges and intense competition. The company continues to strengthen its consumer base and enhance its profitability through strong top-line growth and operational efficiency. Moreover, Uber addressed investors' fears about the impact of autonomous vehicle (AV) adoption on its ride-sharing business by turning it into an opportunity via multiple strategic deals, including that with Alphabet's (GOOGL) Waymo. On Tuesday, Uber announced a partnership with U.K.-based AV startup Wayve to launch a fully driverless robotaxi service in London. Is UBER Stock a Buy or Sell Right Now? Following the announcement of the launch date of Tesla's Robotaxi offering in Austin, BMO Capital analyst Brian Pitz reiterated a Buy rating on Uber Technologies stock with a price target of $101, calling it a Top Pick. The 5-star analyst stated that the pullback in UBER stock in reaction to this news was expected. That said, Pitz remains bullish on UBER stock due to its continued international expansion (including the purchase of Denmark's largest Taxi company, Dantaxi), persistent favorable trends for AV adoption in Austin, and ongoing innovation in both Mobility and Eats. Pitz contends that investors' concerns look overblown, as recent data in Austin remains robust for Uber and the overall U.S. user base remains stable. Additionally, he highlighted that the difference in scale, with Tesla's (TSLA) initial strategy of 10-20 vehicles in Austin on Day 1 vs. hundreds of Waymo vehicles on the Uber platform in the upcoming months creating a favorable backdrop for Uber. Overall, Pitz believes that Uber Technologies remains an 'AV Winner,' with over 15 AV partners and the upcoming launch of shared AV Rides in 2026. With 30 Buys and four Holds, Uber Technologies stock scores a Strong Buy consensus rating. The average UBER stock price target of $99 indicates a 15% upside potential. UBER stock has rallied 43% year-to-date. Conclusion Wall Street is highly bullish on Strategy and Uber Technologies stocks and cautiously optimistic on Super Micro Computer. Analysts currently see higher upside potential in MSTR than in the other two large-cap stocks. Wall Street is upbeat on Strategy stock, as it is an attractive Bitcoin proxy. Investors should be aware of the fact that, given its crypto exposure, MSTR stock is a high-risk, high-reward play.
Yahoo
an hour ago
- Yahoo
GameStop sees 17% dip in Q1 2025 net sales
US videogame and merchandise retailer GameStop has announced its financial results for the first quarter (Q1) ended 3 May 2025, revealing net sales of $732.4m, down from $881.8m in the same period of 2024. The company has consistently faced challenges due to a shift in consumer habits, moving from buying physical games to preferring digital downloads, streaming services and online purchases. GameStop observed a shift in sales mix between the period. Hardware and accessories experienced a drop in net sales and their percentage of total sales decreased from 57.3% to 47.1%. Software sales also saw a reduction in their share of total sales from 27.2% to 24%, while collectibles experienced an increase in net sales and their share of total sales. After the end of the quarter, GameStop completed the divestiture of its Canadian operations on 4 May. The company also purchased 4,710 Bitcoin between 3 May and 10 June, using cash. The company has seen a significant reduction in operating loss, down to $10.8m for the period, compared to $50.6m in Q1 2024. It transitioned from a net loss of $32.3m for Q1 2024 to a net income of $44.8m in Q1 2025. The operating loss includes $35.5m of impairment charges connected to international restructuring efforts. The company's selling, general and administrative expenses decreased to $228.1m from $295.1m year-on-year. When adjusting for impairment charges and other items, GameStop's operating income stood at $27.5m, compared to an adjusted operating loss of $55m in Q1 2024. The company's liquidity position has also strengthened, with cash, cash equivalents and marketable securities totalling $6.4bn at the end of the quarter, up from $1bn at the close of the previous year's first quarter. In the quarter, the company's management agreed to a plan to offload its operations in France. The sale is expected to complete during the fiscal year 2025. "GameStop sees 17% dip in Q1 2025 net sales" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
